Wilmer Eye Institute | Strategic Alliance Partners

Optimal performance has a limited window.

The destination of Marco Island, Florida not only serves as an excellent backdrop for this year's Ophthalmology Times® EyeCon 2022 but also provides a unique opportunity for family members to see their ophthalmic loved ones in a professional light.

Co-chairs Peter J. McDonnell, MD, director of the Wilmer Eye Institute at Johns Hopkins University School of Medicine in Baltimore, Maryland, and Oluwatosin U. Smith, MD, of Glaucoma Associates of Texas in Dallas break down the top reasons to attend this year's Ophthalmology Times® EyeCon 2022 in a series of video segments.

Surveys have found that burnout among physicians who deliver “primary care” is so bad that 20% of them intend to stop practicing.

According to a study published in 2016, approximately 250,000 deaths occur in the United States each year due to medical errors.

While there is currently no cure for blindness, an artificial vision system has undergone its first successful implantation, bringing with it the potential to restore partial vision to people who have lost their sight.

A team of investigators are working on a simple test that may someday identify those who can stop therapy.

Ophthalmologists continue to rise to the challenge amid myriad hurdles.